Vanda Pharma (VNDA) Sees Activity On Takeover Speculation
Up)
Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA) is seeing some interest on some vague takeover speculation. Shares are up 1% on heavier-than-normal volume. The call options are also seeing interest today.
Shares of Vanda have surged over 10x since announcing FDA approval for its schizophrenia drug in early-May.
Shares of Vanda have surged over 10x since announcing FDA approval for its schizophrenia drug in early-May.
You May Also Be Interested In
- Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
- AIG (AIG) Slumps as NY Fed Delays $1.7B Maiden Lane III Debt Sale
- China Investment may nab $2B stake in Alibaba - Reuters
Create E-mail Alert Related Categories
RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
